Risk factors of portal vein thrombosis after splenectomy in patients with liver cirrhosis

Abstract

Portal vein thrombosis (PVT) is a common complication after splenectomy, causing a possible negative impact on the prognosis of patients with liver cirrhosis. However, the risk factors of PVT are not completely clear. Many factors are related to the occurrence of postoperative PVT, such as hemodynamic changes, splenomegaly, splenectomy, coagulation and anticoagulation disorder, liver cirrhosis, platelet count, D-dimer level, infection, inflammation, and other factors.Hemodynamic changes are mainly caused by thicker portal and splenic vein diameters, larger spleen, slower portal vein blood flow rate, lower portal vein pressure before and after surgery, etc. It is timely detection and advanced prevention that really matter in reducing PVT incidence and improving patient prognosis. We systematically reviewed the researches on the risk factors and therapies of PVT to provide useful information on a comprehensive understanding for researchers.

Keywords

Liver cirrhosis / splenectomy / portal vein thrombosis / risk factors / treatments / prophylaxis

References

[1] Zhang X,Yu M,Deng D.Effective prevention for portal venous system thrombosis after splenectomy: a meta-analysis..J Laparoendosc Adv Surg Tech A2017;27:247-52

[2] Hashizume M,Akahoshi T,Gotoh N.Laparoscopic splenectomy for portal hypertension..Hepatogastroenterology2002;49:847-52

[3] Raja K,Asthana S.Portal vein thrombosis in cirrhosis..J Clin Exp Hepatol2014;4:320-31 PMCID:PMC4298635

[4] Targarona EM.Portal vein thrombosis after laparoscopic splenectomy: the size of the risk..Surg Innov2008;15:266-70

[5] Krauth MT,Neugebauer EA.The postoperative splenic/portal vein thrombosis after splenectomy and its prevention - an unresolved issue..Haematologica2008;93:1227-32

[6] Kinjo N,Akahoshi T,Yamashita N.Risk factors for portal venous thrombosis after splenectomy in patients with cirrhosis and portal hypertension..Br J Surg2010;97:910-6

[7] Yoshida M,Horiuchi A,Sugishita H.Portal and splenic venous thrombosis after splenectomy in patients with hypersplenism..Hepatogastroenterology2009;56:538-41

[8] Xu X,De Stefano V,Goyal H.Nonselective beta-blockers and development of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis..Hepatol Int2019;13:468-81

[9] Huang XL,Zhang JK.Risk factors of portal vein thrombosis after surgery for advanced schistosomiasis portal hypertension..Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi2015;27:177-9(in Chinese)

[10] Kuroki T,Tokunaga T,Taniguchi K.Predictors of portal and splenic vein thrombosis after laparoscopic splenectomy: a retrospective analysis of a single-center experience..Surg Today2018;48:804-9

[11] Wu S,Zhang X,Bai J.The incidence and risk factors of portal vein system thrombosis after splenectomy and pericardial devascularization..Turk J Gastroenterol2015;26:423-8

[12] Harding DJ,Chen F,Tripathi D.Portal vein thrombosis in cirrhosis: controversies and latest developments..World J Gastroenterol2015;21:6769-84 PMCID:PMC4462717

[13] Jiang GQ,Chen P,Jin SJ.Risk factors for portal vein system thrombosis after laparoscopic splenectomy in cirrhotic patients with hypersplenism..J Laparoendosc Adv Surg Tech A2016;26:419-23

[14] Qi X,Liu X,Han G.Novel insights into the development of portal vein thrombosis in cirrhosis patients..Expert Rev Gastroenterol Hepatol2015;9:1421-32

[15] Zocco MA,De Cristofaro R,Ainora ME.Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development..J Hepatol2009;51:682-9

[16] Huang L,Wang J.Association between changes in splanchnic hemodynamics and risk factors of portal venous system thrombosis after splenectomy with periesophagogastric devascularization..Med Sci Monit2018;24:4355-62 PMCID:PMC6048999

[17] Nery F,Condat B,Boudaoud L.Groupe d’Etude et de Traitement du Carcinome H. Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal study..Hepatology2015;61:660-7

[18] Abdel-Razik A,Elhelaly R.De-novo portal vein thrombosis in liver cirrhosis: risk factors and correlation with the model for end-stage liver disease scoring system..Eur J Gastroenterol Hepatol2015;27:585-92

[19] Trebicka J.Etiology and complications of portal vein thrombosis..Viszeralmedizin2014;30:375-80 PMCID:PMC4513836

[20] Dai J,Peng Y,Chen J.Association between D-dimer level and portal venous system thrombosis in liver cirrhosis: a retrospective observational study..Int J Clin Exp Med2015;8:15296-301 PMCID:PMC4658906

[21] Bolognesi M,Sacerdoti D,Gatta A.Role of spleen enlargement in cirrhosis with portal hypertension..Dig Liver Dis2002;34:144-50

[22] McCormick PA.Splenomegaly, hypersplenism and coagulation abnormalities in liver disease..Baillieres Best Pract Res Clin Gastroenterol2000;14:1009-31

[23] Romano A,Sertorio M,Cabantous S.FOXP3+ regulatory T cells in hepatic fibrosis and splenomegaly caused by schistosoma japonicum: the spleen may be a major source of tregs in subjects with splenomegaly..PLoS Negl Trop Dis2016;10:e0004306 PMCID:PMC4701139

[24] Stamou KM,Kekis PB,Gafou A.Prospective study of the incidence and risk factors of postsplenectomy thrombosis of the portal, mesenteric, and splenic veins..Arch Surg2006;141:663-9

[25] Wang M,Li J,Wu Z.Risk factors of portal vein thrombosis in patients with beta thalassemia major after splenectomy: laparoscopic versus open procedure..Hepatogastroenterology2014;61:48-54

[26] Ikeda M,Takiguchi S,Ikenaga M.High incidence of thrombosis of the portal venous system after laparoscopic splenectomy: a prospective study with contrast-enhanced CT scan..Ann Surg2005;241:208-16 PMCID:PMC1356904

[27] Pietrabissa A,Antonelli G,Marciano E.Thrombosis in the portal venous system after elective laparoscopic splenectomy..Surg Endosc2004;18:1140-3

[28] Danno K,Sekimoto M,Takemasa I.Diameter of splenic vein is a risk factor for portal or splenic vein thrombosis after laparoscopic splenectomy..Surgery2009;145:457-64discussion 65-6

[29] Li MX,Liu ZW.Risk factors and clinical characteristics of portal vein thrombosis after splenectomy in patients with liver cirrhosis..Hepatobiliary Pancreat Dis Int2013;12:512-9

[30] Sun L,Gu L,Liu Y.Effects of surgical procedures on the occurrence and development of postoperative portal vein thrombosis in patients with cirrhosis complicated by portal hypertension..Int J Surg2015;16:31-5

[31] Bai DS,Zhang C,Qian JJ.Warfarin versus aspirin prevents portal vein thrombosis after laparoscopic splenectomy and azygoportal disconnection: A randomized clinical trial..Int J Surg2019;64:16-23

[32] Zheng S,Liu X,Gong W.Efficacy and safety of laparoscopic splenectomy and esophagogastric devascularization for portal hypertension: a single-center experience..Medicine2018;97:e13703 PMCID:PMC6320041

[33] Bao H,Dai N,Zhang Q.Retrospective study to compare selective decongestive devascularization and gastrosplenic shunt versus splenectomy with pericardial devascularization for the treatment of patients with esophagogastric varices due to cirrhotic portal hypertension..Med Sci Monit2017;23:2788-95 PMCID:PMC5472402

[34] de’Angelis N,Lizzi V,Genova P.Incidence and predictors of portal and splenic vein thrombosis after pure laparoscopic splenectomy..Surgery2017;162:1219-30

[35] Eyraud D,Ionescu C,Darnat S.Thrombocytopenia, splenomegaly, and portal blood flow in patients who have undergone liver transplantation for cirrhosis..Liver Transpl2012;18:340-6

[36] Guan YS.Clinical application of partial splenic embolization..Sci World J2014;2014:961345 PMCID:PMC4235844

[37] Kheradpir MH.Partial splenectomy and partial splenic attachment for the treatment of portal hypertension..Z Kinderchir1990;45:98-9

[38] Sretenovic A,Vujovic D,Vukadinovic V.Warren shunt combined with partial splenectomy in children with extra-hepatic portal hypertension, massive splenomegaly and severe hypersplenism..Srp Arh Celok Lek2014;142:419-23

[39] Zhe C,Jian C,Ping B.Laparoscopic versus open splenectomy and esophagogastric devascularization for bleeding varices or severe hypersplenism: a comparative study..J Gastrointest Surg2013;17:654-9

[40] Stine JG,Cornella SL,Ghabril MS.Portal vein thrombosis, mortality and hepatic decompensation in patients with cirrhosis: a meta-analysis..World J Hepatol2015;7:2774-80 PMCID:PMC4663397

[41] Jiang GQ,Chen P,Jin SJ.Anticoagulation therapy with warfarin versus low-dose aspirin prevents portal vein thrombosis after laparoscopic splenectomy and azygoportal disconnection..J Laparoendosc Adv Surg Tech A2016;26:517-23

[42] Vecchio R,Cacciola RR,Intagliata E.Portal vein thrombosis after laparoscopic and open splenectomy..J Laparoendosc Adv Surg Tech A2011;21:71-5

[43] Leonardi F,Villa E.Anticoagulation in cirrhosis: a new paradigm?.Clin Mol Hepatol2017;23:13-21 PMCID:PMC5381832

[44] Monroe DM.The coagulation cascade in cirrhosis..Clin Liver Dis2009;13:1-9

[45] Primignani M,La Mura V.Therapeutic and clinical aspects of portal vein thrombosis in patients with cirrhosis..World J Hepatol2015;7:2906-12 PMCID:PMC4678377

[46] Tripodi A,Chantarangkul V,Clerici M.An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis..Gastroenterology2009;137:2105-11

[47] Tripodi A,Lemma L,Mannucci PM.Evidence that low protein C contributes to the procoagulant imbalance in cirrhosis..J Hepatol2013;59:265-70

[48] Qi X,Han G.Effect of antithrombin, protein C and protein S on portal vein thrombosis in liver cirrhosis: a meta-analysis..Am J Med Sci2013;346:38-44

[49] Rodriguez-Leal GA,Corona-Cedillo R.Portal vein thrombosis with protein C-S deficiency in a non-cirrhotic patient..World J Hepatol2014;6:532-7 PMCID:PMC4110546

[50] Kawanaka H,Kinjo N,Yoshida D.Impact of antithrombin III concentrates on portal vein thrombosis after splenectomy in patients with liver cirrhosis and hypersplenism..Ann Surg2010;251:76-83

[51] Kawanaka H,Itoh S,Harimoto N.Optimizing risk stratification in portal vein thrombosis after splenectomy and its primary prophylaxis with antithrombin III concentrates and danaparoid sodium in liver cirrhosis with portal hypertension..J Am Coll Surg2014;219:865-74

[52] Han J,Ding H,Zhang Y.Preoperative risk factors of portal venous thrombosis after splenectomy and gastric pericardial devascularization for portal hypertension..Zhonghua Gan Zang Bing Za Zhi2014;22:739-43(in Chinese)

[53] Zhang Y,Yan LN,Deng XF.Preoperative predictors of portal vein thrombosis after splenectomy with periesophagogastric devascularization..World J Gastroenterol2012;18:1834-9 PMCID:PMC3332299

[54] Rossetto V,Senzolo M,Gavasso S.Does decreased fibrinolysis have a role to play in the development of non-neoplastic portal vein thrombosis in patients with hepatic cirrhosis?.Intern Emerg Med2014;9:397-403

[55] Smalberg JH,Darwish Murad S,Seijo S.European Network for Vascular Disorders of the L. Fibrinogen gamma’ and variation in fibrinogen gamma genes in the etiology of portal vein thrombosis..Thromb Haemost2013;109:558-60

[56] Kinjo N,Akahoshi T,Kamori M.Portal vein thrombosis in liver cirrhosis..World J Hepatol2014;6:64-71 PMCID:PMC3934638

[57] Qi X,Ren W,Jia J.Association between portal vein thrombosis and risk of bleeding in liver cirrhosis: a systematic review of the literature..Clin Res Hepatol Gastroenterol2015;39:683-91

[58] Zhang N,Xue W.Early prophylactic anticoagulation for portal vein system thrombosis after splenectomy: a systematic review and meta-analysis..Biomed Rep2016;5:483-90 PMCID:PMC5038582

[59] Huang D,Cao L,Zheng S.Risk factors and anticoagulation effects of portal vein system thrombosis after laparoscopic splenectomy in patients with or without cirrhosis..Surg Laparosc Endosc Percutan Tech2019;29:498-502

[60] Nadinskaia MY,Ulyanova KA,Rogacheva SI.Risk factors associated with portal vein thrombosis in liver cirrhosis: a case-control study..Ter Arkh2019;91:73-81

[61] Hernandez Conde M,de la Revilla Negro J,Fernandez Puga N.Prevalence and outcome of portal thrombosis in a cohort of cirrhotic patients undergoing liver transplantation..Rev Esp Enferm Dig2016;108:716-20

[62] Tarzamni MK,Farhang S.Portal hemodynamics as predictors of high risk esophageal varices in cirrhotic patients..World J Gastroenterol2008;14:1898-902 PMCID:PMC2700414

[63] Chawla YK.Portal vein thrombosis..J Clin Exp Hepatol2015;5:22-40 PMCID:PMC4415192

[64] Francoz C,Durand F.Portal vein thrombosis, cirrhosis, and liver transplantation..J Hepatol2012;57:203-12

[65] Machado NO,Sankhla D.Portal vein thrombosis postlaparoscopic splenectomy presenting with infarction of gut: review of risk factors, investigations, postoperative surveillance, and management..Surg Laparosc Endosc Percutan Tech2010;20:273-7

[66] Griesshammer M,Sauer T,Bergmann L.Aetiology and clinical significance of thrombocytosis: analysis of 732 patients with an elevated platelet count..J Intern Med1999;245:295-300

[67] Coppinger JA,Toomey S,Belton O.Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions..Blood2004;103:2096-104

[68] Ghanima W,Cines DB.How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment..Blood2012;120:960-9

[69] He S.Predictive model of portal venous system thrombosis in cirrhotic portal hypertensive patients after splenectomy..Int J Clin Exp Med2015;8:4236-42 PMCID:PMC4443169

[70] Wang L,Chen YX,Zhang YQ.Combined use of D-dimer and P-selectin for the diagnosis of splenic or portal vein thrombosis following splenectomy..Thromb Res2010;125:e206-9

[71] Hirashita T,Kai S,Eguchi H.Implications of portal vein thrombosis after splenectomy for patients with idiopathic portal hypertension..Surg Today2011;41:1475-80

[72] Qi X,Li H,Guo X.Anticoagulation for the treatment of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis of observational studies..Eur J Intern Med2015;26:23-9

[73] Bates SM,Johnston M,Kovacs MJ.A latex D-dimer reliably excludes venous thromboembolism..Arch Intern Med2001;161:447-53

[74] Shorr AF,Alkins SA,Ling GS.D-dimer correlates with proinflammatory cytokine levels and outcomes in critically ill patients..Chest2002;121:1262-8

[75] Kinasewitz GT,Basson B,Russell JA.Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569]..Crit Care2004;8:R82-90 PMCID:PMC420030

[76] Di Sabatino A,Corazza GR.Post-splenectomy and hyposplenic states..Lancet2011;378:86-97

[77] Levi M.Disseminated intravascular coagulation: an update on pathogenesis and diagnosis..Expert Rev Hematol2018;11:663-72

[78] Levi M,ten Cate H.The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia..Eur J Clin Invest1997;27:3-9

[79] van der Poll T,Hack CE,van Deventer SJ.Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees..J Exp Med1994;179:1253-9 PMCID:PMC2191443

[80] Osterud B,Olsen JO.Induction of tissue factor expression in whole blood: lack of evidence for the presence of tissue factor expression in granulocytes..Thromb Haemost2000;83:861-7

[81] Franco RF,Dekkers PE,Spek CA.The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulation..Blood2000;96:554-9

[82] Furie B.Role of platelet P-selectin and microparticle PSGL-1 in thrombus formation..Trends Mol Med2004;10:171-8

[83] Campillo B,Bories PN.Validation of body mass index for the diagnosis of malnutrition in patients with liver cirrhosis..Gastroenterol Clin Biol2006;30:1137-43

[84] Ponziani FR,Campanale C,Tortora A.Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment..World J Gastroenterol2010;16:143-55 PMCID:PMC2806552

[85] Amitrano L,Brancaccio V,Manguso F.Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis..J Hepatol2004;40:736-41

[86] Dentali F,Gianni M.Inherited thrombophilic abnormalities and risk of portal vein thrombosis. a meta-analysis..Thromb Haemost2008;99:675-82

[87] Zhou JB,Liu CW.Effects of early antiplatelet therapy after splenectomy with gastro-oesophageal devascularization..ANZ J Surg2018;88:E725-9 PMCID:PMC6175465

[88] Zakko A,Nankani R.Obesity is not associated with an increased risk of portal vein thrombosis in cirrhotic patients..Gastroenterol Hepatol Bed Bench2018;11:153-8 PMCID:PMC5990917

[89] Eshraghian A,Kazemi K,Shamsaeefar A.Portal vein thrombosis in patients with liver cirrhosis and its impact on early and long-term outcomes after liver transplantation..Int J Clin Pract2018;e13309:

[90] Hu KQ,Tiyyagura L,Reynolds TB.Hyperfibrinolytic activity in hospitalized cirrhotic patients in a referral liver unit..Am J Gastroenterol2001;96:1581-6

[91] Villa E,Marietta M,Critelli R.Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis..Gastroenterology2012;143:1253-60.e4

[92] Valentin N,Constantino J,Weisberg I.The role of transjugular intrahepatic portosystemic shunt in the management of portal vein thrombosis: a systematic review and meta-analysis..Eur J Gastroenterol Hepatol2018;30:1187-93

[93] Romualdi E.Investigational factor Xa inhibitors for thrombosis and acute coronary syndromes..Expert Opin Investig Drugs2011;20:495-505

[94] Millan M,Villegas JI,Caicedo L.Case report of cadaveric kidney transplantation with renal-portal venous drainage: a feasible way for a venous drainage in a complex generalized thrombosed vessels setting..Int J Surg Case Rep2016;28:192-5 PMCID:PMC5061305

[95] Lai W,Li GY,Wu JS.Anticoagulation therapy prevents portal-splenic vein thrombosis after splenectomy with gastroesophageal devascularization..World J Gastroenterol2012;18:3443-50 PMCID:PMC3396198

[96] Delgado MG,Yepes I,Catalina MV.Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis..Clin Gastroenterol Hepatol2012;10:776-83

[97] Cheng Z,Tian J,Li J.A comparative study of two anti-coagulation plans on the prevention of PVST after laparoscopic splenectomy and esophagogastric devascularization..J Thromb Thrombolysis2015;40:294-301

[98] Tripodi A.The coagulopathy of chronic liver disease..N Engl J Med2011;365:147-56

[99] Lenz K,Buder R,Rauch M.Successful treatment of partial portal vein thrombosis (PVT) with low dose rivaroxaban..Z Gastroenterol2014;52:1175-7

[100] Yang H,Song MJ.Recurrent acute portal vein thrombosis in liver cirrhosis treated by rivaroxaban..Clin Mol Hepatol2016;22:499-502 PMCID:PMC5266341

[101] Potze W,Adelmeijer J,van den Berg AP.Differential in vitro inhibition of thrombin generation by anticoagulant drugs in plasma from patients with cirrhosis..PLoS One2014;9:e88390 PMCID:PMC3913782

[102] Artaza T,Romero M,de la Cruz G.Efficacy and safety of anticoagulation in non-malignant portal vein thrombosis in patients with liver cirrhosis..Gastroenterol Hepatol2018;41:611-7

[103] Qi X,Wang J,Fan D.Degree of portal vein thrombosis..Hepatology2010;51:1089-90

[104] Senzolo M,Rossetto V,Cillo U.Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis..Liver Int2012;32:919-27

[105] Gaba RC.Transjugular intrahepatic portosystemic shunt for maintenance of portal venous patency in liver transplant candidates..J Clin Imaging Sci2013;3:28 PMCID:PMC3779400

[106] Lakhoo J.Outcomes of transjugular intrahepatic portosystemic shunt creation for flow-enabled dissolution of spleno-mesenterico-portal venous thrombosis..Diagn Interv Imaging2016;97:1085-93

[107] Riggio O,Lucidi C.Emerging issues in the use of transjugular intrahepatic portosystemic shunt (TIPS) for management of portal hypertension: time to update the guidelines?.Dig Liver Dis2010;42:462-7

[108] Inagaki Y,Shiraki K,Kusagawa S.The long-term effects of splenectomy and subsequent interferon therapy in patients with HCV-related liver cirrhosis..Mol Med Rep2014;9:487-92

[109] Yang S,Fan X,Wu X.Early prophylactic anticoagulation via transjugular intrahepatic route for portal vein thrombosis after splenectomy in cirrhotic portal hypertension..J Vasc Interv Radiol2015;26:1009-17

[110] Shang CZ,Zhang HW,Cao J.Splenic autotransplantation combined with lower esophagus transaction in the treatment of hepatic cirrhosis induced portal hypertension..Zhonghua Wai Ke Za Zhi2009;47:83-5(in Chinese)

[111] Shan HJ,Zhuo W,Zhihao Z.Portal veinous hemodynamics after subtotal splenectomy and portaazygous devascularization..Zhongguo Putong Waike Zazhi2010;25:20-3

[112] Zhu Y.Analysis of 26 cases of autotransplantation of spleen tissue after splenectomy..Clin Med Chin2004;20:459-60(in Chinese)